TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment of Stage IV and Recurrent Renal Cell Cancer
Source: Renal Cell Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 13, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Continue within this section
Treatment Options for First-Line Therapy for Stage IV Renal Cell Cancer →Treatment Options for Second-Line Therapy for Stage IV Renal Cell Cancer →Treatment Options for Third- and Fourth-Line Therapy for Stage IV Renal Cell Cancer →Immunotherapy →Combined Immune Checkpoint Inhibitors and Antiangiogenic Targeted Therapies →Local Therapy →Antiangiogenic and Other Targeted Therapy →Combined Therapy With Multitargeted TKIs and mTOR Inhibitors →Chemotherapy →
Preserved source evidence · Not medical advice